Study (ref no.) | Year | Country | No. patients | Standard | Method | Cut-off (mg/l) | TP | FP | FN | TN | QUADAS score | Misclassified* | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exu | Trans | ||||||||||||
Hamm H [16] | 1987 | Germany | 31 | 31 | Clinical criteria | ECM | 60 | 28 | 3 | 3 | 28 | 8 | 9/30 |
Valdés L [17] | 1991 | Spain | 188 | 65 | Clinical criteria | ECM | 55 | 171 | 0 | 17 | 65 | 9 | 14/65 |
Romero S [18] | 1993 | Spain | 253 | 44 | Clinical criteria | ECM | 60 | 206 | 4 | 47 | 40 | 8 | 10/44 |
Burgess LJ [19] | 1995 | South Africa | 270 | 123 | Clinical criteria | ESM | 50 | 184 | 11 | 86 | 112 | 7 | 19/112 |
Costa M [20] | 1995 | Chile | 131 | 49 | Clinical criteria | ECM | 45 | 118 | 0 | 13 | 49 | 9 | 9/49 |
Gil Suay V [21] | 1995 | Spain | 156 | 48 | Clinical criteria | ECM | 54 | 149 | 4 | 7 | 44 | 8 | 17/48 |
Garcia-Pachon E [22] | 1996 | Spain | 118 | 35 | Clinical criteria | NA | 50 | 107 | 1 | 11 | 34 | 10 | 9/35 |
Kalayci AG [23] | 1996 | Turkey | 40 | 20 | Clinical criteria | ECM | 40 | 36 | 1 | 4 | 19 | 9 | NA |
MetintaÅŸ M [24] | 1997 | Turkey | 72 | 21 | Clinical criteria | ECM | 60 | 54 | 3 | 18 | 18 | 10 | 4/21 |
Gázquez I [25] | 1998 | Spain | 155 | 38 | Clinical criteria | ECM | 50 | 130 | 6 | 25 | 32 | 7 | 11/38 |
Romero S [26] | 2000 | Spain | 182 | 61 | Clinical criteria | ECM | 60 | 155 | 5 | 27 | 56 | 9 | 9/61 |
Yilmaz A [27] | 2000 | Turkey | 150 | 105 | Clinical criteria | ECM | 60 | 143 | 4 | 7 | 101 | 8 | 13/105 |
Porcel JM [28] | 2001 | Spain | 139 | 32 | Clinical criteria | ECM | 60 | 111 | 1 | 28 | 31 | 9 | 8/32 |
Alexandrakis MG [29] | 2002 | Greece | 82 | 24 | Light's criteria | NA | 65 | 76 | 0 | 6 | 24 | 10 | NA |
Guleria R [30] | 2003 | India | 50 | 25 | Clinical criteria | NA | 60 | 44 | 0 | 6 | 25 | 9 | 5/25 |
Leers MP [31] | 2007 | Netherlands | 300 | 108 | Clinical criteria | ECM | 60 | 227 | 2 | 73 | 106 | 11 | 29/108 |
Razi E [32] | 2008 | Iran | 70 | 49 | Light's criteria | NA | 38 | 61 | 10 | 9 | 39 | 8 | NA |
Hamal AB [33] | 2013 | Nepal | 43 | 19 | Clinical criteria | ECM | 45 | 42 | 0 | 1 | 19 | 12 | NA |
Patel AK [34] | 2013 | India | 49 | 11 | Clinical criteria | NA | 60 | 48 | 0 | 1 | 11 | 11 | 0/11 |